News : 2013

Francisco Vega, M.D., Ph.D.

Lymphoma Expert Joins the Department of Pathology to Diagnose and Research Blood Cancers

Francisco Vega, M.D., Ph.D., an expert in the diagnosis and investigation of cancers arising from the blood and lymphatic system, has been appointed director of hematopathology in the Department of Pathology. Formerly head of the Lymphoma Section at MD Anderson Cancer Center’s Department of Hematopathology, Vega officially joined the Miller School and Sylvester Comprehensive Cancer Center September 1.

Read more »

Anthony Williams, left, celebrates his award with Michael Lomax, President and CEO of the United Negro College Fund (UNCF), at the UNCF-Merck Science Initiative Fellows Day.

Graduate Student Receives Prestigious Fellowship for His Accomplishments and Promise

Anthony Williams, a Ph.D. candidate in the Miller School’s Sheila and David Fuente Graduate Program in Cancer Biology, is one of just 12 graduate students across the nation to receive a 2013 United Negro College Fund/Merck Graduate Science Research Dissertation Fellowship.

Read more »

Ronald Desrosiers, Ph.D.

Harvard Virologist Joins UM’s Fight Against HIV/AIDS and Cancer

Ronald Desrosiers, Ph.D., a virologist whose seminal discoveries at Harvard Medical School fueled scientific hopes of developing a vaccine for HIV/AIDS, has joined the Miller School’s Department of Pathology, where he will serve as Director of Research Faculty Development and continue his basic science research into viruses that cause AIDS and cancer.

Read more »

Richard M. Awdeh, M.D.

Bascom Palmer Researchers Discover Novel Way to Detect Ocular Disease

In a study led by Richard M. Awdeh, M.D., assistant professor of clinical ophthalmology, researchers at Bascom Palmer Eye Institute have discovered a novel use for optical coherence tomography to detect molecular markers and improve diagnosis of ocular disease.

Read more »

Richard J. Cote, M.D.

Smoking Intensity and Cancer Markers Predict Seriousness of Bladder Cancer

Smoking not only causes bladder cancer, it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a study published January 14 in CANCER, a peer-reviewed journal of the American Cancer Society.

Read more »

Ferenc Rick, M.D., Ph.D., Andrew Schally, Ph.D., M.D.h.c., D.Sc.h.c., and Norman Block, M.D.

Growth Hormone Study Could Lead to New Drug Therapies for Alzheimer’s Disease

A team of Miller School and Miami VA Medical Center researchers has developed a synthetic antagonist of growth hormone-releasing hormone (GHRH) that holds promise for a new drug therapy to reverse or stop the progression of Alzheimer’s disease.

Read more »